PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28495631-1	2017	We report the synthesis of Ag2S-Chitosan nanocomposites and Ag2S-chitosan nanohybrids as performance adsorbents for Lincosamides such as Clindamycin antibiotic removal.	Clindamycin	137-148	angiotensin II receptor type 1	Homo sapiens	27-31	
28495631-1	2017	We report the synthesis of Ag2S-Chitosan nanocomposites and Ag2S-chitosan nanohybrids as performance adsorbents for Lincosamides such as Clindamycin antibiotic removal.	Clindamycin	137-148	angiotensin II receptor type 1	Homo sapiens	60-64	
28495631-5	2017	In particular, Ag2S-Chitosan nanocomposites and Ag2S-chitosan nanohybrids show high maximum Clindamycin adsorption capacity (qmax) of 153.21, and 181.28mgg-1, respectively.	Clindamycin	92-103	angiotensin II receptor type 1	Homo sapiens	15-19	
28495631-5	2017	In particular, Ag2S-Chitosan nanocomposites and Ag2S-chitosan nanohybrids show high maximum Clindamycin adsorption capacity (qmax) of 153.21, and 181.28mgg-1, respectively.	Clindamycin	92-103	angiotensin II receptor type 1	Homo sapiens	48-52	
28495631-6	2017	More strikingly, Ag2S-Chitosan nanocomposites and Ag2S-chitosan nanohybrids are also demonstrated to nearly completely remove Clindamycin from drinking water.	Clindamycin	126-137	angiotensin II receptor type 1	Homo sapiens	17-21	
28495631-6	2017	More strikingly, Ag2S-Chitosan nanocomposites and Ag2S-chitosan nanohybrids are also demonstrated to nearly completely remove Clindamycin from drinking water.	Clindamycin	126-137	angiotensin II receptor type 1	Homo sapiens	50-54